‘Drastic’ Japan Price Reforms Hitting R&D Incentives, Plans - EFPIA

 
• By Ian Haydock

European research-based pharma group proposes reconsideration of Japan’s revised pricing system, warning it is already affecting corporate R&D decisions and will stifle industry investment, innovation and patient access to new therapies if incentives are not improved.

Tokyo skyline and Mountain Fuji in Japan
EFPIA Proposes Changes To Japan Pricing Scheme • Source: Shutterstock

More from Japan

More from Focus On Asia